A 5-month, randomized, placebo-controlled trial of galanthamine in AD - Tariot,P.N.; Solomon,P.R.; Morris,J.C.; Kershaw,P.; Lilienfeld,S.; Ding,C and the Galantamine USA-10 Study Group. (Neurology, 2000)